PDB Short entry for 1OZ1 HEADER TRANSFERASE 07-APR-03 1OZ1 TITLE P38 MITOGEN-ACTIVATED KINASE IN COMPLEX WITH 4-AZAINDOLE TITLE 2 INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: MITOGEN-ACTIVATED PROTEIN KINASE 14; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: MITOGEN-ACTIVATED PROTEIN KINASE P38ALPHA, MAP COMPND 5 KINASE P38ALPHA, CYTOKINE SUPPRESSIVE ANTI-INFLAMMATORY COMPND 6 DRUG BINDING PROTEIN, CSAID BINDING PROTEIN, CSBP, MAX- COMPND 7 INTERACTING PROTEIN 2, MAP KINASE MXI2, SAPK2A; COMPND 8 EC: 2.7.1.37; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MAPK14 OR CSBP1 OR CSBP2 OR CSBP OR MXI2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: M15[PREP4]; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_VECTOR: PQE9 KEYWDS SER/THR PROTEIN KINASE, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR B.LOVEJOY,A.VILLASENOR,M.BROWNER,P.DUNTEN REVDAT 3 24-FEB-09 1OZ1 1 VERSN REVDAT 2 21-SEP-04 1OZ1 1 JRNL REVDAT 1 23-SEP-03 1OZ1 0 JRNL AUTH A.TREJO,H.ARZENO,M.BROWNER,S.CHANDA,S.CHENG, JRNL AUTH 2 D.D.COMER,S.A.DALRYMPLE,P.DUNTEN,J.LAFARGUE, JRNL AUTH 3 B.LOVEJOY,J.FREIRE-MOAR,J.LIM,J.MCINTOSH,J.MILLER, JRNL AUTH 4 E.PAPP,D.REUTER,R.ROBERTS,F.SANPABLO,J.SAUNDERS, JRNL AUTH 5 K.SONG,A.VILLASENOR,S.D.WARREN,M.WELCH,P.WELLER, JRNL AUTH 6 P.E.WHITELEY,L.ZENG,D.M.GOLDSTEIN JRNL TITL DESIGN AND SYNTHESIS OF 4-AZAINDOLES AS INHIBITORS JRNL TITL 2 OF P38 MAP KINASE. JRNL REF J.MED.CHEM. V. 46 4702 2003 JRNL REFN ISSN 0022-2623 JRNL PMID 14561090 JRNL DOI 10.1021/JM0301787 REMARK 1 REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.1.24 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 85.7 REMARK 3 NUMBER OF REFLECTIONS : 25244 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.204 REMARK 3 R VALUE (WORKING SET) : 0.201 REMARK 3 FREE R VALUE : 0.251 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1271 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.10 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.15 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1828 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2220 REMARK 3 BIN FREE R VALUE SET COUNT : 108 REMARK 3 BIN FREE R VALUE : 0.2790 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2779 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 23 REMARK 3 SOLVENT ATOMS : 201 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 29.20 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 27.74 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.17000 REMARK 3 B22 (A**2) : 0.15000 REMARK 3 B33 (A**2) : 1.02000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.227 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.200 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.121 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 4.449 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.945 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.912 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2870 ; 0.016 ; 0.021 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3900 ; 1.366 ; 1.964 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 342 ; 5.795 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): NULL ; NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 435 ; 0.096 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2175 ; 0.006 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1267 ; 0.211 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 210 ; 0.130 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 28 ; 0.127 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 13 ; 0.105 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1721 ; 0.859 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2793 ; 1.570 ; 2.000 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1149 ; 2.266 ; 3.000 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1107 ; 3.564 ; 4.500 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1OZ1 COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 09-APR-03. REMARK 100 THE RCSB ID CODE IS RCSB018821. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 04-AUG-97 REMARK 200 TEMPERATURE (KELVIN) : 110 REMARK 200 PH : 7.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : SIEMENS REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : GRAPHITE REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 25274 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 85.8 REMARK 200 DATA REDUNDANCY : 4.800 REMARK 200 R MERGE (I) : 0.09900 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 7.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.17 REMARK 200 COMPLETENESS FOR SHELL (%) : 89.3 REMARK 200 DATA REDUNDANCY IN SHELL : 4.80 REMARK 200 R MERGE FOR SHELL (I) : 0.45500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 56.92 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.86 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 3350, CALCIUM CHLORIDE, HEPES REMARK 280 BUFFER, PH 7.6, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 290K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 22.70250 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 62.92050 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 42.72700 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 62.92050 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 22.70250 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 42.72700 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -11 REMARK 465 GLY A -10 REMARK 465 ARG A -9 REMARK 465 SER A -8 REMARK 465 HIS A -7 REMARK 465 HIS A -6 REMARK 465 HIS A -5 REMARK 465 HIS A -4 REMARK 465 HIS A -3 REMARK 465 HIS A -2 REMARK 465 GLY A -1 REMARK 465 SER A 0 REMARK 465 MET A 1 REMARK 465 SER A 2 REMARK 465 GLN A 3 REMARK 465 GLU A 4 REMARK 465 LYS A 118 REMARK 465 CYS A 119 REMARK 465 GLN A 120 REMARK 465 LYS A 121 REMARK 465 LEU A 353 REMARK 465 ASP A 354 REMARK 465 GLN A 355 REMARK 465 GLU A 356 REMARK 465 GLU A 357 REMARK 465 MET A 358 REMARK 465 GLU A 359 REMARK 465 SER A 360 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A 101 CB - CG - OD2 ANGL. DEV. = 6.1 DEGREES REMARK 500 ASP A 161 CB - CG - OD2 ANGL. DEV. = 5.4 DEGREES REMARK 500 ASP A 294 CB - CG - OD2 ANGL. DEV. = 5.9 DEGREES REMARK 500 ASP A 321 CB - CG - OD2 ANGL. DEV. = 6.2 DEGREES REMARK 500 ASP A 331 CB - CG - OD2 ANGL. DEV. = 5.4 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 14 59.44 22.59 REMARK 500 LYS A 15 -1.44 71.82 REMARK 500 ASN A 100 -33.76 -138.52 REMARK 500 ASN A 115 37.03 -74.95 REMARK 500 ILE A 116 -45.27 -142.04 REMARK 500 ARG A 149 -14.08 77.91 REMARK 500 ASP A 168 88.77 85.44 REMARK 500 LEU A 289 58.98 -94.03 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FPH A 500 DBREF 1OZ1 A 1 360 UNP Q16539 MK14_HUMAN 1 360 SEQADV 1OZ1 MET A -11 UNP Q16539 EXPRESSION TAG SEQADV 1OZ1 GLY A -10 UNP Q16539 EXPRESSION TAG SEQADV 1OZ1 ARG A -9 UNP Q16539 EXPRESSION TAG SEQADV 1OZ1 SER A -8 UNP Q16539 EXPRESSION TAG SEQADV 1OZ1 HIS A -7 UNP Q16539 EXPRESSION TAG SEQADV 1OZ1 HIS A -6 UNP Q16539 EXPRESSION TAG SEQADV 1OZ1 HIS A -5 UNP Q16539 EXPRESSION TAG SEQADV 1OZ1 HIS A -4 UNP Q16539 EXPRESSION TAG SEQADV 1OZ1 HIS A -3 UNP Q16539 EXPRESSION TAG SEQADV 1OZ1 HIS A -2 UNP Q16539 EXPRESSION TAG SEQADV 1OZ1 GLY A -1 UNP Q16539 EXPRESSION TAG SEQADV 1OZ1 SER A 0 UNP Q16539 EXPRESSION TAG SEQRES 1 A 372 MET GLY ARG SER HIS HIS HIS HIS HIS HIS GLY SER MET SEQRES 2 A 372 SER GLN GLU ARG PRO THR PHE TYR ARG GLN GLU LEU ASN SEQRES 3 A 372 LYS THR ILE TRP GLU VAL PRO GLU ARG TYR GLN ASN LEU SEQRES 4 A 372 SER PRO VAL GLY SER GLY ALA TYR GLY SER VAL CYS ALA SEQRES 5 A 372 ALA PHE ASP THR LYS THR GLY LEU ARG VAL ALA VAL LYS SEQRES 6 A 372 LYS LEU SER ARG PRO PHE GLN SER ILE ILE HIS ALA LYS SEQRES 7 A 372 ARG THR TYR ARG GLU LEU ARG LEU LEU LYS HIS MET LYS SEQRES 8 A 372 HIS GLU ASN VAL ILE GLY LEU LEU ASP VAL PHE THR PRO SEQRES 9 A 372 ALA ARG SER LEU GLU GLU PHE ASN ASP VAL TYR LEU VAL SEQRES 10 A 372 THR HIS LEU MET GLY ALA ASP LEU ASN ASN ILE VAL LYS SEQRES 11 A 372 CYS GLN LYS LEU THR ASP ASP HIS VAL GLN PHE LEU ILE SEQRES 12 A 372 TYR GLN ILE LEU ARG GLY LEU LYS TYR ILE HIS SER ALA SEQRES 13 A 372 ASP ILE ILE HIS ARG ASP LEU LYS PRO SER ASN LEU ALA SEQRES 14 A 372 VAL ASN GLU ASP CYS GLU LEU LYS ILE LEU ASP PHE GLY SEQRES 15 A 372 LEU ALA ARG HIS THR ASP ASP GLU MET THR GLY TYR VAL SEQRES 16 A 372 ALA THR ARG TRP TYR ARG ALA PRO GLU ILE MET LEU ASN SEQRES 17 A 372 TRP MET HIS TYR ASN GLN THR VAL ASP ILE TRP SER VAL SEQRES 18 A 372 GLY CYS ILE MET ALA GLU LEU LEU THR GLY ARG THR LEU SEQRES 19 A 372 PHE PRO GLY THR ASP HIS ILE ASP GLN LEU LYS LEU ILE SEQRES 20 A 372 LEU ARG LEU VAL GLY THR PRO GLY ALA GLU LEU LEU LYS SEQRES 21 A 372 LYS ILE SER SER GLU SER ALA ARG ASN TYR ILE GLN SER SEQRES 22 A 372 LEU THR GLN MET PRO LYS MET ASN PHE ALA ASN VAL PHE SEQRES 23 A 372 ILE GLY ALA ASN PRO LEU ALA VAL ASP LEU LEU GLU LYS SEQRES 24 A 372 MET LEU VAL LEU ASP SER ASP LYS ARG ILE THR ALA ALA SEQRES 25 A 372 GLN ALA LEU ALA HIS ALA TYR PHE ALA GLN TYR HIS ASP SEQRES 26 A 372 PRO ASP ASP GLU PRO VAL ALA ASP PRO TYR ASP GLN SER SEQRES 27 A 372 PHE GLU SER ARG ASP LEU LEU ILE ASP GLU TRP LYS SER SEQRES 28 A 372 LEU THR TYR ASP GLU VAL ILE SER PHE VAL PRO PRO PRO SEQRES 29 A 372 LEU ASP GLN GLU GLU MET GLU SER HET FPH A 500 23 HETNAM FPH 3-(4-FLUOROPHENYL)-2-PYRIDIN-4-YL-1H-PYRROLO[3,2- HETNAM 2 FPH B]PYRIDIN-1-OL HETSYN FPH 3-(4-FLUOROPHENYL)-1-HYDROXY-2-(PYRIDIN-4-YL)-1H- HETSYN 2 FPH PYRROLO[3,2-B]PYRIDINE FORMUL 2 FPH C18 H12 F N3 O FORMUL 3 HOH *201(H2 O) HELIX 1 1 SER A 61 MET A 78 1 18 HELIX 2 2 THR A 123 ALA A 144 1 22 HELIX 3 3 LYS A 152 SER A 154 5 3 HELIX 4 4 VAL A 183 TYR A 188 1 6 HELIX 5 5 ALA A 190 LEU A 195 1 6 HELIX 6 6 THR A 203 GLY A 219 1 17 HELIX 7 7 ASP A 227 GLY A 240 1 14 HELIX 8 8 GLY A 243 LYS A 248 1 6 HELIX 9 9 SER A 252 GLN A 260 1 9 HELIX 10 10 ASN A 269 PHE A 274 1 6 HELIX 11 11 ASN A 278 LEU A 289 1 12 HELIX 12 12 THR A 298 ALA A 304 1 7 HELIX 13 13 HIS A 305 ALA A 309 5 5 HELIX 14 14 ASP A 313 GLU A 317 5 5 HELIX 15 15 GLN A 325 ARG A 330 5 6 HELIX 16 16 LEU A 333 SER A 347 1 15 SHEET 1 A 2 PHE A 8 LEU A 13 0 SHEET 2 A 2 THR A 16 PRO A 21 -1 O TRP A 18 N GLN A 11 SHEET 1 B 5 TYR A 24 GLY A 33 0 SHEET 2 B 5 GLY A 36 ASP A 43 -1 O PHE A 42 N GLN A 25 SHEET 3 B 5 ARG A 49 LEU A 55 -1 O VAL A 52 N CYS A 39 SHEET 4 B 5 TYR A 103 HIS A 107 -1 O LEU A 104 N LYS A 53 SHEET 5 B 5 ASP A 88 PHE A 90 -1 N ASP A 88 O VAL A 105 SHEET 1 C 3 ALA A 111 ASP A 112 0 SHEET 2 C 3 LEU A 156 VAL A 158 -1 O VAL A 158 N ALA A 111 SHEET 3 C 3 LEU A 164 ILE A 166 -1 O LYS A 165 N ALA A 157 SITE 1 AC1 9 TYR A 35 ALA A 51 LYS A 53 LEU A 104 SITE 2 AC1 9 VAL A 105 THR A 106 HIS A 107 MET A 109 SITE 3 AC1 9 HOH A 701 CRYST1 45.405 85.454 125.841 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.022024 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011702 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007947 0.00000